Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

308
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
308
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

99
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
99
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

311
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
311

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex-based differences in long-term mortality after TAVR among patients with bicuspid aortic valve.

Cardiovascular revascularization medicine : including molecular interventions·2026
Same author

Fate of dilated ascending aorta after transcatheter aortic valve replacement.

JTCVS structural and endovascular·2026
Same author

On-Scene, Residential Extracorporeal Cardiopulmonary Resuscitation for Refractory Out-of-Hospital Cardiac Arrest: Operational and Logistical Considerations.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

Hemodynamic-guided V-A ECMO management for cardiogenic shock: Insight from initial experience from TWEET study (to wean an ECMO trials).

Perfusion·2026
Same author

Left Ventricular Venting Strategies for Cardiogenic Shock in Patients Treated With Extracorporeal Cardiopulmonary Support V-A ECMO: From Left Ventricular Unloading to Offloading.

The American journal of cardiology·2026
Same author

Therapeutic Plasma Exchange for Uncontrollable Bleeding After Platelet Inhibition with Ticagrelor: A Report of 2 Cases.

The American journal of case reports·2026

Related Experiment Video

Updated: Nov 6, 2025

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

35.6K

Off-Pump Continuous-Flow Left Ventricular Assist Device Implantation.

Ismael A Salas De Armas1,2, Jayeshkumar A Patel1,2, Mehmet H Akay1,2

  • 1Department of Advanced Cardiopulmonary Therapies and Transplantation, University of Texas Health Science Center at Houston, Houston, Texas.

Texas Heart Institute Journal
|May 4, 2021
PubMed
Summary

Continuous-flow left ventricular assist devices offer a treatment for end-stage heart failure. An innovative off-pump surgical technique for implanting these devices, specifically the HeartWare system, is detailed to minimize physiological stress.

Keywords:
Cardiopulmonary bypass/adverse effectsequipment designheart failure/surgeryheart-assist devicespostoperative complications/prevention & controlprosthesis implantation/methodstreatment outcome

More Related Videos

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.4K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.8K

Related Experiment Videos

Last Updated: Nov 6, 2025

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

35.6K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.4K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.8K

Area of Science:

  • Cardiovascular Surgery
  • Medical Devices
  • Heart Failure Treatment

Background:

  • Continuous-flow left ventricular assist devices (CF-LVADs) are standard for end-stage heart failure.
  • Current implantation methods often require cardiopulmonary bypass, potentially causing adverse physiological effects.
  • Advancements in device technology and surgical management have improved short-term outcomes.

Purpose of the Study:

  • To present an innovative off-pump surgical technique for CF-LVAD implantation.
  • To detail the surgical methodology for the HeartWare CF-LVAD using an off-pump approach.
  • To explore methods for minimizing adverse physiological effects during LVAD implantation.

Main Methods:

  • Development and description of a novel off-pump surgical technique for CF-LVAD implantation.
  • Focus on the HeartWare device implantation procedure.
  • Surgical technique emphasizes minimizing cardiopulmonary bypass-associated complications.

Main Results:

  • The study details a specific surgical technique for off-pump CF-LVAD implantation.
  • The described method aims to reduce the physiological impact of LVAD surgery.
  • This approach may offer an alternative to traditional on-pump procedures.

Conclusions:

  • An off-pump implantation approach for continuous-flow left ventricular assist devices has been developed.
  • The presented surgical technique for the HeartWare device offers a potential alternative to on-pump implantation.
  • Minimizing cardiopulmonary bypass may lead to improved patient outcomes in LVAD surgery.